Tencent invests $30m into HK-based early cancer detection firm
Insighta, valued at $200m, uses a system designed to detect DNA methylation aberrations in cell-free DNA in bodily fluids such as blood; Prenetics has reduced its stake in the firm.
October 16, 2024